J Engellau

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma
    J Engellau
    Department of Oncology, Lund University Hospital, Sweden
    Appl Immunohistochem Mol Morphol 9:358-63. 2001
  2. ncbi request reprint Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays
    Jacob Engellau
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Hum Pathol 36:994-1002. 2005
  3. ncbi request reprint Identification of low-risk tumours in histological high-grade soft tissue sarcomas
    J Engellau
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Eur J Cancer 43:1927-34. 2007
  4. ncbi request reprint Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
    Jacob Engellau
    Department of Oncology, The Jubileum Institute, Lund University, Lund, Sweden
    Cancer 100:2233-9. 2004
  5. ncbi request reprint Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67
    Jacob Engellau
    Department of Oncology, Jubileum Institution, Lund University, 22185 Lund, Sweden
    Virchows Arch 445:224-30. 2004
  6. ncbi request reprint Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence
    Jacob Engellau
    Department of Oncology, Lund University Hospital, Lund University, Sweden
    Acta Orthop Scand Suppl 75:2 p preceding table of contents-52, backcover. 2004
  7. ncbi request reprint Experiences from tissue microarray in soft tissue sarcomas
    M Nilbert
    Dept of Oncology, University Hospital, Lund, Sweden
    Acta Orthop Scand Suppl 75:29-34. 2004
  8. pmc Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients
    J Fernebro
    Department of Oncology, Institute of Clinical Sciences, Lund University Hospital, Lund, Sweden
    Br J Cancer 95:986-90. 2006
  9. ncbi request reprint Fine-needle aspiration of neurilemoma (schwannoma). A clinicocytopathologic study of 116 patients
    Henryk A Domanski
    Department of Pathology and Cytology, Lund University Hospital, Lund, Sweden
    Diagn Cytopathol 34:403-12. 2006
  10. ncbi request reprint Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center
    Josefin Fernebro
    Department of Oncology, Institute of Clinical Sciences, Lund University Hospital, Lund, Sweden
    APMIS 115:707-12. 2007

Detail Information

Publications12

  1. ncbi request reprint Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma
    J Engellau
    Department of Oncology, Lund University Hospital, Sweden
    Appl Immunohistochem Mol Morphol 9:358-63. 2001
    ..The feasibility of tissue microarray for immunohistochemical studies of soft tissue sarcomas offers new possibilities to study multiple markers in large tumor materials...
  2. ncbi request reprint Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays
    Jacob Engellau
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Hum Pathol 36:994-1002. 2005
    ....
  3. ncbi request reprint Identification of low-risk tumours in histological high-grade soft tissue sarcomas
    J Engellau
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Eur J Cancer 43:1927-34. 2007
    ..15. The model was validated in an independent material of 175 patients. This model improved prognostication in STS and is of value for identifying patients who probably should not receive adjuvant chemotherapy...
  4. ncbi request reprint Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
    Jacob Engellau
    Department of Oncology, The Jubileum Institute, Lund University, Lund, Sweden
    Cancer 100:2233-9. 2004
    ..Prognostic factors for metastasis in soft tissue sarcoma govern decisions regarding adjuvant treatment. However, the significance of initial tumor-related prognostic factors over time is largely unknown...
  5. ncbi request reprint Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67
    Jacob Engellau
    Department of Oncology, Jubileum Institution, Lund University, 22185 Lund, Sweden
    Virchows Arch 445:224-30. 2004
    ..Hence, we suggest that proliferation, as measured by Ki-67 index, should be considered as a prognostic marker in clinical management of pleomorphic soft tissue sarcomas...
  6. ncbi request reprint Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence
    Jacob Engellau
    Department of Oncology, Lund University Hospital, Lund University, Sweden
    Acta Orthop Scand Suppl 75:2 p preceding table of contents-52, backcover. 2004
    ..4) were independent prognostic factors. Finally, prognostic factors were found to be time-dependent, and most had lost their prognostic value after 2 years, whereas LR was a strong prognostic factor for metastasis whenever it occurred...
  7. ncbi request reprint Experiences from tissue microarray in soft tissue sarcomas
    M Nilbert
    Dept of Oncology, University Hospital, Lund, Sweden
    Acta Orthop Scand Suppl 75:29-34. 2004
    ..We review the TMA method, its reproducibility, advantages, limitations and future perspectives with specific focus on soft tissue sarcomas...
  8. pmc Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients
    J Fernebro
    Department of Oncology, Institute of Clinical Sciences, Lund University Hospital, Lund, Sweden
    Br J Cancer 95:986-90. 2006
    ..6; 95% CI=8.1-33.5; P<0.001). Hence, this population-based series demonstrates a high frequency of second primary tumours among STS patients and indicates a particularly increased risk of developing a new STS...
  9. ncbi request reprint Fine-needle aspiration of neurilemoma (schwannoma). A clinicocytopathologic study of 116 patients
    Henryk A Domanski
    Department of Pathology and Cytology, Lund University Hospital, Lund, Sweden
    Diagn Cytopathol 34:403-12. 2006
    ..Furthermore aspirates showing predominantly Antoni A features, nuclear pleomorphism, and/or myxoid changes can easily be confused with other types of benign or malignant soft-tissue tumors...
  10. ncbi request reprint Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center
    Josefin Fernebro
    Department of Oncology, Institute of Clinical Sciences, Lund University Hospital, Lund, Sweden
    APMIS 115:707-12. 2007
    ..Our findings suggest that the determination of proliferation in soft tissue sarcomas should be standardized for clinical application of Ki-67 as a prognostic marker...
  11. ncbi request reprint Core-needle biopsy performed by the cytopathologist: a technique to complement fine-needle aspiration of soft tissue and bone lesions
    Henryk A Domanski
    Department of Pathology and Cytology, Lund University Hospital, Lund, Sweden
    Cancer 105:229-39. 2005
    ..The main limitation of FNAC of soft tissue and bone neoplasms is in the evaluation of tissue architecture. In addition cytologic specimens are not always adequate for ancillary studies...
  12. ncbi request reprint Molecular cytogenetic characterization of an ins(4;X) occurring as the sole abnormality in an aggressive, poorly differentiated soft tissue sarcoma
    Cecilia Surace
    Department of Clinical Genetics, Lund University Hospital, SE 221 85, Lund, Sweden
    Virchows Arch 447:869-74. 2005
    ..Our results suggest that BCOR and/or an ECM-like protein could be involved in the pathogenesis of a subgroup of PNET or PNET-like sarcomas...